GlassScriptPhysician profile
David C Kmak
NPI 1700826252
$923.85
in general payments reported to CMS, 2019-2025
14 companies · $99.93 in 2025
The $99.93 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $73.39 · 2021: $60.09 · 2022: $191 · 2023: $200 · 2024: $139 · 2025: $99.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.10 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $269.27 | 2022-2025 | Acessa Provu System, Fluent Fluid Management System, Aptima |
| Astellas Pharma US INC | $189.23 | 2023-2025 | Veozah |
| Abbvie INC. | $107.99 | 2019-2021 | |
| Aspira Women'S Health INC | $75.72 | 2019-2022 | |
| Coopersurgical, INC. | $56.33 | 2020-2023 | Paragard T 380a |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Lupin INC. | $37.44 | 2019-2020 | |
| Novo Nordisk INC | $34.03 | 2024 | |
| Medtronic, INC. | $22.24 | 2022 | |
| Evofem Biosciences, INC. | $21.36 | 2021 | |
| Dysis Medical, INC. | $19.99 | 2022 | |
| Gynesonics, INC. | $18.43 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $18.37 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kmak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.